Prophylactic Use of Antibiotics for Through and Through Lacerations of the Lip
Information source: University of Pennsylvania
Information obtained from ClinicalTrials.gov on October 19, 2009 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Through-and-through Lip Lacerations
Intervention: keflex (Drug); peridex (Drug); placebo (Drug)
Phase: N/A
Status: Not yet recruiting
Sponsored by: University of Pennsylvania Official(s) and/or principal investigator(s): Carrie Sims, M.D., Principal Investigator, Affiliation: University of Pennsylvania
Overall contact: Joli Chou, M.D., D.M.D., Phone: 215 662-3580, Email: joli.chou@uphs.upenn.edu
Summary
Facial lacerations are a commonly encountered problem in the emergency department. Despite
this, few original articles have been written concerning the management of lacerations of
the lip which communicate with the oral cavity. Specifically, no study has been able to
definitively show whether the use of antibiotics for these wounds decreases the infection
rate. These cutaneous wounds are a unique type of laceration because they are continuously
contaminated with oropharyngeal flora. Contaminated wounds result in larger, less cosmetic
scars. Scars which involve the face have been shown to have a negative psychological impact.
In this study, the investigators aim to determine whether the use of antibiotics decrease
the rate of infection in lacerations of the lip which communicate with the oral cavity.
Patients will be randomized to one of three currently practiced therapies. Patients will
receive either cephalexin, chlorhexidine or no treatment following the repair of their
through-and-through lip lacerations to determine whether antibiotics decrease the infection
rate in these wounds.
Clinical Details
Official title: Prophylactic Use of Antibiotics for Through and Through Lacerations of the Lip
Study design: Treatment, Randomized, Double Blind (Subject, Outcomes Assessor), Placebo Control, Single Group Assignment, Efficacy Study
Primary outcome: infection
Secondary outcome: scar formation
Detailed description:
Facial lacerations are commonly encountered problem in trauma and emergency room patients
1,2. Soft tissue trauma of the face can cause significant psychological impact 4. Wound care
and the need to minimize scarring is particularly important in this region 4. There have
been many studies evaluating the management of soft tissue injuries in general 1, 5. For
example, simple lacerations of the hand do not benefit from antibiotic therapy 5. The need
for antibiotics for full thickness lacerations of the lip, however, has received little
attention 3. Full thickness lacerations of the lip are defined as wounds that violate the
mucosa, underlying muscle and skin (i. e through-and through lacerations). These
oral-cutaneous injuries constitute a unique type of injury in that the laceration exposes
the skin and underlying soft tissue to microbes of the oral pharynx that are normally
encountered only by intact oral mucosa. This represents a uniquely different flora from that
typically seen in simple skin lacerations. Because these are contaminated wound, there may
be an increased risk for infection and an increased need for prophylactic antibiotics.
Currently, there is no consensus on the prophylactic treatment of oral-cutaneous wounds with
many physicians prescribing oral antibiotics, others utilizing topical antibacterials, and
still others treating with local wound care 3.
A review of the literature found only four original articles addressing the topic of oral
antibiotic prophylaxis3. Two of these four original articles suffer serious methodological
flaws. The first, published in 1965, was a prospective observational study which was neither
blinded, nor specified the type or duration of antibiotic therapy 6. Despite these flaws,
the study demonstrated a non-significant trend toward benefit with antibiotics 6. Of
interest, the author noted all wounds older than 24 hours not treated with antibiotics
became infected 6.
The second article, published in 1970 by Paterson et. was a prospective randomized trial,
though the type and duration of antibiotic treatment in the intervention arm was left to the
discretion of the treating clinician 7. The author combined both mucosal only oral
lacerations and oral-cutaneous wounds. Wound infection was deemed to be present in 18. 5% of
patients treated with antibiotics versus 4. 3% of those receiving no treatment (RR = 4. 32,
95% CI = 1. 30 to 14. 31) 7. None of the patients with mucosa-only wounds developed wound
infections; all infections were seen in patients with "through-and-through" lacerations 7.
Despite this, the authors concluded that the role of prophylactic antibiotics is
questionable in preventing local infection 7.
The third article was a prospective, randomized study in the pediatric population evaluating
all intra-oral lacerations 8. In this study 4. 3% of patients treated with prophylactic
penicillin had evidence of wound infection at follow-up, versus 8. 5% of patients in the
control arm (RR = 0. 51, 95% CI = 0. 10 to 2. 65)8. The authors conclude that given the low
background rate of infection in this study (8. 5%), their study was markedly underpowered,
and severely limited their ability to make any conclusions regarding the efficacy of
prophylactic antibiotics 8.
Finally, in 1989, Steele et al. randomized 62 adult patients presenting within 24 hours of
injury to a single emergency department with full-thickness intraoral or
"through-and-through" lacerations to either treatment with oral antibiotics (penicillin VK
for 5 days) or placebo therapy 9. Among patients treated with penicillin prophylaxis, 6. 7%
developed wound infection versus 18. 8% in the placebo group (RR = 0. 36, 95% CI = 0. 08 to
1. 63) 9. In a subgroup analysis of patients who were perfectly compliant with therapy by
pill counts, there were no infections in the penicillin arm versus 17. 9% in the placebo arm
(p = 0. 054 using two-tailed Fisher exact test) 9. The authors alternatively reported this as
a statistically significant finding, using a one-tailed Fisher exact test, which yields a p
value of 0. 027. Furthermore, in subgroup analysis of "through-and-though" lacerations, 7% (1
out of 14) versus 27% (4 out of 15) of patients developed wound infection in the treatment
and placebo groups, respectively (RR = 0. 27, 95% CI = 0. 03 to 2. 12) 9. Overall the authors
conclude that while they cannot conclusively recommend prophylactic penicillin for adults
with intraoral lacerations treated within 24 hours of injury, though there may be a trend
towards benefit 9. They also suggest that patients with "through-and-through" wounds may
benefit proportionally more from prophylaxis 9.
Despite the authors' inability to make conclusive recommendations from the available data,
many textbooks cite these references and recommend the routine use of antibiotics for
oral-cutaneous wounds10-14. Many other text books, on the other hand, do not address this
topic at all10-14. Our study aims to answer the question of whether or not antibiotics
reduce wound infection rates in through-and-through lacerations of the lip with a dedicated
antibiotic regimen evaluated prospectively.
The type of antibiotic used to prophylactically treat oral-cutaneous wounds also remains
controversial among clinicians. Previous studies have utilized penicillin V K. Penicillin,
however, does not fully cover the flora typically cultured in infected oral-cutaneous
wounds. 9 Cephalexin is well described in the literature as an appropriate choice for
oropharyngeal infections and has appropriate skin flora coverage, thereby, making it an
ideal antibiotic for the prophylaxis of oral-cutaneous wounds 15.
The second treatment group chosen was chlorhexidine gluconate 0. 12% solution. This
medication is typically used to treat periodontal disease, but has also been studied as a
prophylactic agent for perioperative maxillofacial surgery. Significant adverse reactions
(>10%) include tooth staining when used longer than a week. 16 This side-effect is reversible
with dental cleanings. In a retrospective review of periodontal procedures, the prophylactic
use of chlorhexidine rinse showed a lower infection rate for these intraoral procedures17.
In addition, it has been suggested in emergency medicine literature, that Cholrhexidine may
be a useful agent in the prevention of infection in these wounds. 18 We feel that prospective
study of this agent is warranted.
Current practice concerning the use of antibiotics for oral-cutaneous wounds varies
greatly10-14. Many textbooks either do not address the topic or cite inconclusive
evidence10-14. A thorough search of the literature revealed only four original articles 3.
No article was able to produce significant results and the trends and recommendations were
mixed 3. Currently, there is no consensus regarding the treatment of oral cutaneous wounds
and patients are treated with oral antibiotics, topical antibacterials, or local wound care
depending on the treating physician's preference 3. It is important to determine the best
treatment protocol for these unique wounds.
Eligibility
Minimum age: 18 Months.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- any individual who presents with a through-and-through laceration of the lip within
twenty-four hours of injury
Exclusion Criteria:
- patients less than eighteen years of age
- pregnancy
- currently taking antibiotics
- animal or human bites
- wounds greater than 24 hours old
- diabetic patients
- immune compromised patients
- patients who require antibiotics for other sustained injuries
- patients with an allergy to penicillin or cephalosporin will be excluded if
randomized to the cephalexin treatment group
Locations and Contacts
Joli Chou, M.D., D.M.D., Phone: 215 662-3580, Email: joli.chou@uphs.upenn.edu
Hopital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States
Additional Information
Starting date: August 2009
Ending date: August 2011
Last updated: August 12, 2009
|